A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2011
11/24/2011	US20110286980 Methods for inducing selective apoptosis
11/24/2011	US20110286971 Targeted drug-carrying bacteriophages
11/24/2011	US20110286968 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
11/24/2011	US20110286966 Inhibitor of Endogenous Human Interferon-gamma
11/24/2011	US20110286964 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
11/24/2011	US20110286960 Cancer therapy by docetaxel and granulocyte colony-stimulating factor (g-csf)
11/24/2011	US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011	US20110286938 Non-invasive detection of complement-mediated inflammation using cr2-targeted nanoparticles
11/24/2011	US20110286926 Degradable hydrogel compositions and methods
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	CA2800348A1 Il-12 formulations for enhancing hematopoiesis
11/24/2011	CA2800174A1 Antigen specific tregs and related compositions, methods and systems
11/24/2011	CA2799904A1 Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors
11/24/2011	CA2799764A1 Mtor selective kinase inhibitors
11/24/2011	CA2799579A1 Chemical compounds, compositions and methods for kinase modulation
11/24/2011	CA2799202A1 Compositions and methods for treatment of autoimmune and other diseases
11/24/2011	CA2798970A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/23/2011	EP2388590A1 PD-1, a receptor for B7-4, and uses thereof
11/23/2011	EP2388277A2 Human anti-B7RP1 neutralizing antibodies
11/23/2011	EP2388276A2 Human anti-B7RP1 neutralizing antibodies
11/23/2011	EP2388275A2 An aglycosylated IgG1 antibody to CD3
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388010A1 Use of non-digestible saccharides for giving an infant the best start after birth
11/23/2011	EP2387609A2 Non-embryonic stem cells and uses thereof
11/23/2011	EP2387587A1 Recombinant monovalent antibodies
11/23/2011	EP2387571A1 Oxadiazole derivatives as slpl receptor agonists
11/23/2011	EP2387325A2 Methods for improving hepatic and immune function in an animal
11/23/2011	EP1951674B1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
11/23/2011	EP1904048B1 Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
11/23/2011	EP1864659B1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
11/23/2011	EP1735277B1 2-alkylidene-18,19-dinor-vitamin d compounds
11/23/2011	EP1569937B1 C-6 modified indazolylpyrrolotriazines
11/23/2011	EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
11/23/2011	EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011	EP1362105B1 Anti-interferon-alpha antibodies
11/23/2011	EP1349576B1 Combined use of enzyme inhibitors for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with follicular and epidermal hyperkeratosis and reinforced keratinocyte proliferation
11/23/2011	EP1296715B1 Multivalent vaccine composition
11/23/2011	EP1137439B2 Stabilization of rapamycins or derivatives of rapamycins
11/23/2011	CN202048757U Freeze dryer used for freeze-drying Cordyceps sinensis
11/23/2011	CN1902229B IL-18 binding proteins
11/23/2011	CN1832960B Immunomodulating compositions, uses therefor and processes for their production
11/23/2011	CN102257138A Tumor antigen peptide and use thereof
11/23/2011	CN102256989A Anionic conjugates of glycosylated bacterial metabolite
11/23/2011	CN102256943A Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid
11/23/2011	CN102256933A Organic compounds
11/23/2011	CN102256612A Composition containing extracts of fuscoporia obliqua, ganoderma lucidum and phellinus linteus for promoting the proliferation of hematopoietic stem cells
11/23/2011	CN102250984A Method for preparing functional extracellular polysaccharide of lactic acid bacteria
11/23/2011	CN102250918A Recombinant human interferon-like proteins
11/23/2011	CN102250738A Health-care wine and production process thereof
11/23/2011	CN102250734A Linearstripe rabdosia herb combined propolis wine and preparation method thereof
11/23/2011	CN102250733A Health-care wine matched with gynostemma pentaphylla and preparation method thereof
11/23/2011	CN102250732A Tussah female moth beautifying wine for women, and production process thereof
11/23/2011	CN102250706A Grape wine with nourishing function
11/23/2011	CN102250254A Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) fusion protein, its preparation and applications
11/23/2011	CN102250243A Antibody to interleukins-15
11/23/2011	CN102250185A Glucocorticoid with NMDA ester positioned on site 21
11/23/2011	CN102250085A Bifendate derivative and use thereof in preparation of drugs for treating autoimmune diseases
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN102250035A Synthesis method and medicinal purpose of diaryl substituted-1,3,4-oxadiazole compounds
11/23/2011	CN102247592A Novel application of ubiquitin-like modified protein in resisting virus
11/23/2011	CN102247540A Renal function health-care wine
11/23/2011	CN102247539A Chinese medicinal health care wine
11/23/2011	CN102247530A Tall gastrodia tuber spirit for resisting fatigue and enhancing immunity
11/23/2011	CN102247487A Chinese medicinal preparation and use thereof
11/23/2011	CN102247420A Preparation method and application of eclipta extract
11/23/2011	CN102247419A Health-care Chinese medicinal composition
11/23/2011	CN102247403A Liquid nanometer selenium and preparation method thereof
11/23/2011	CN102247364A Compound medical application and preparation thereof
11/23/2011	CN102247350A Application of eriocalyxin to preparation of medicaments for treating autoimmune diseases
11/23/2011	CN102247330A Sustained release tablet prepared from raw material of safflower yellow and preparation method thereof
11/23/2011	CN102247319A Thymalfasin-containing medicinal composition and preparation method thereof
11/23/2011	CN101953927B External Chinese medicinal liniment for treating urticaria
11/23/2011	CN101732540B Method for determining effective component of total glycoside in smilax glabra ethanol water solution extract
11/23/2011	CN101716213B Traditional Chinese medicine effective fraction composition for detoxification and lipid lowering and preparation method thereof
11/23/2011	CN101712957B Toll-like receptor 9 (TLR9) blocking agent and application thereof
11/23/2011	CN101700255B Compound fermentation glossy ganoderma capsule and preparation method thereof
11/23/2011	CN101697981B Fast, non-heat change and high-efficiency method for breaking ganoderma lucidum spore
11/23/2011	CN101550192B Monoclonal antibody K42-D2 of antihuman granzyme K and hybridoma cell line for excreting same
11/22/2011	US8063087 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
11/22/2011	US8063051 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators
11/22/2011	US8063045 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
11/22/2011	CA2558509C Tetrahydropyridoindole derivatives
11/22/2011	CA2513655C Use of tryptanthrin compounds for immune potentiation
11/22/2011	CA2494762C Pharmaceutical compositions comprising cyclosporin for oral administration
11/22/2011	CA2489902C Thiazole derivatives as phosphodiesterase iv inhibitors
11/22/2011	CA2486917C Topically applicable pharmaceutical preparation containing roflumilast
11/22/2011	CA2484395C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
11/22/2011	CA2482973C Microparticles comprising carbohydrate beads covalently linked with allergen
11/22/2011	CA2455392C Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
11/22/2011	CA2372511C Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/22/2011	CA2344740C Mutant cholera holotoxin as an adjuvant
11/17/2011	WO2011143484A1 A sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (dmard) and an anti-cancer agent
11/17/2011	WO2011143482A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
11/17/2011	WO2011143162A1 Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
11/17/2011	WO2011143106A1 Bi - functional pyrazolopyridine compounds
11/17/2011	WO2011142316A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity
11/17/2011	WO2011141713A1 New bicyclic compounds as pi3-k and mtor inhibitors
11/17/2011	WO2011141474A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/17/2011	WO2011113798A3 Inhibitors of semicarabazide - sensitive amine oxidase
11/17/2011	WO2011105902A3 Antagonists of complement component 8-beta (c8-beta) and uses thereof

1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 1172